The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Abstract
The hypoxia-inducible factors (HIFs) 1α and 2α are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress. This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel–Lindau (VHL tumor suppressor) ubiquitin ligase. We now show that hypoxic induction of the COOH-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD. Inhibitors of Fe(II)- and 2-oxoglutarate–dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator. Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity. Full induction of HIF-1α and -2α, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degradation and COOH-terminal transactivation domains, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was recently shown that HIFα association with p300 is blocked under normoxic conditions by hydroxylation of a conserved asparagine residue within the CAD (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“As with HIF prolyl hydroxylases, endogenous HIF asparaginyl hydroxylase activity can be blocked with competitive inhibitors of 2-oxoglutarate and with iron chelators (Lando et al. 2002), suggesting that this enzyme might also resemble known hydroxylase enzymes.”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“HIF transcriptional activity is suppressed under normoxic conditions by hydroxylation of an asparagine residue within its C-terminal transactivation domain, blocking association with coactivators.”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“Full induction of the hypoxic response pathway upon exposure to low oxygen levels requires both stabilization of the HIFα transcription factor and activation of the CAD (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“Asparagine hydroxylation is abrogated by hypoxia, allowing HIF to recruit the larger transcriptional apparatus to hypoxiaresponsive target genes (Lando et al. 2002).”
From FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) · cites this paper as Lando et al. 2002
In the citing paper
“This mechanism attenuates HIF transcriptional activity during early reoxygenation, acting as a buffer that limits the excessive metabolic activation and oxidative stress during the transition from hypoxia to normoxia”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [53]
In the citing paper
“FIH-1 functions at lower oxygen tensions than PHDs and hydroxylates a single asparagine residue within the C-terminal transactivation domain of HIF-1α, consequently limiting engagement of transcriptional co-activator complexes [52,53]”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [53]
In the citing paper
“Hif-1α is also hydroxylated in an oxygen-dependent reaction on a highly conserved asparagine residue by FIH-1 (Factor inhibiting HIF-1), which blocks the ability of Hif-1α to recruit transcriptional coactivators such as p300/CBP, in turn limiting transcriptional activation by Hif-1α under non-hypoxic conditions [45, 46].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [46]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
Ema, M., Taya, S., Yokotani, N., Sogawa, K., Matsuda, Y., & Fujii-Kuriyama, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4273 · Cited by 1,016
HIF-1 and human disease: one highly involved factor
Semenza, G. L. (2000) · Genes & Development · doi:10.1101/gad.14.16.1983 · Cited by 909
Flagged first, then by citations
Research works printed but not linked: 1
- Supplementary material is available on Science Online at www.sciencemag.org/cgi/content/full/295/5556/858/DC1
Cited by
Sorted by citations
Items 501–600 of 1,005
Yeo, E.-J., Ryu, J., Cho, Y.-S., Chun, Y., Huang, E. L., Kim, M., & Park, J. (2005) · Blood · doi:10.1182/blood-2005-06-2564 · Cited by 81
Mitochondrial Regulation of Cell Survival and Death During Low-Oxygen Conditions
Snyder, C. M., & Chandel, N. S. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2730 · Cited by 84
NO and TNF-α released from activated macrophages stabilize HIF-1α in resting tubular LLC-PK1 cells
Zhou, J., Fandrey, J., Schümann, J., Tiegs, G., & Brüne, B. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00294.2002 · Cited by 81
Podocyte Expression of Hypoxia-Inducible Factor (HIF)–1 and HIF–2 during Glomerular Development
Freeburg, P. B., Robert, B., John, P. L. S., & Abrahamson, D. R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000059308.82322.4f · Cited by 82
HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0505 · Cited by 79
Guo, C., Zhang, Y., Wang, T., Zhong, M., Yang, Z., Hao, L.-J., Chai, R., & Zhang, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00104 · Cited by 80
Schultz, L., Chaux, A., Albadine, R., Hicks, J. L., Kim, J., Marzo, A. M. D., Allaf, M. E., Carducci, M. A., Rodríguez, R., Hammers, H.-J., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822895e5 · Cited by 79
Erythropoietin in heart and vessels: focus on transcription and signalling pathways
Marzo, F., Lavorgna, A., Coluzzi, G., Santucci, E., Tarantino, F., Rio, T., Conti, E., Autore, C., Agati, L., & Andreotti, F. (2008) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0212-3 · Cited by 83
Tanaka, T., & Nangaku, M. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283328eed · Cited by 81
Epigenetics: New Questions on the Response to Hypoxia
Perez-Perri, J. I., Acevedo, J. M., & Wappner, P. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12074705 · Cited by 82
Targeting Protein–Protein Interactions in the HIF System
Wilkins, S. E., Abboud, M. I., Hancock, R. L., & Schofield, C. J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600012 · Cited by 81
Chen, H., Davidson, T. L., Singleton, S. T., Garrick, M. D., & Costa, M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.11.011 · Cited by 79
High-Dose Vitamin C for Cancer Therapy
Mussa, A., Idris, R. A. M., Ahmed, N., Ahmad, S., Murtadha, A. H., Din, T. A. D. A. T., Yean, C. Y., Rahman, W. F. W. A., Lazim, N. M., Uskoković, V., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060711 · Cited by 85
Shen, H., Ojo, O. A., Ding, H., Mullen, L. J., Xing, C., Hossain, M. I., Yassin, A., Shi, V. Y., Lewis, Z., Podgórska, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53593-8 · Cited by 90
Chan, D. A., & Giaccia, A. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605682 · Cited by 80
Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone
Koury, M. J. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.06.031 · Cited by 78
Stoller, J. K. (2004) · Thorax · doi:10.1136/thorax.2003.017517 · Cited by 79
The VHL protein recruits a novel KRAB‐A domain protein to repress HIF‐1α transcriptional activity
Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg173 · Cited by 77
Therapeutic Manipulation of the HIF Hydroxylases
Nagel, S., Talbot, N. P., Mecinović, J., Smith, T. G., Buchan, A. M., & Schofield, C. J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2711 · Cited by 77
Chemical and functional aspects of posttranslational modification of proteins.
Knorre, D. G., Kudryashova, N. V., & Godovikova, T. S. (2009) · PubMed Central · Cited by 77
Linke, S., Stojkoski, C., Kewley, R. J., Booker, G. W., Whitelaw, M. L., & Peet, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313614200 · Cited by 79
Self-citationImpaired Oxygen-dependent Reduction of HIF-1α and -2α Proteins in Pre-eclamptic Placentae
Rajakumar, A., Doty, K. D., Daftary, A., Harger, G. F., & Conrad, K. P. (2003) · Placenta · doi:10.1016/s0143-4004(03)00081-x · Cited by 78
Genetic modulation of hypoxia induced gene expression and angiogenesis relevance to brain tumors
Brat, D. J. (2003) · Frontiers in bioscience · doi:10.2741/942 · Cited by 78
Shin, D. H., Dier, U., Melendez, J. A., & Hempel, N. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.001 · Cited by 77
Hypoxia and Oxygen-Sensing Signaling in Gene Regulation and Cancer Progression
Yang, G., Shi, R., & Zhang, Q. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218162 · Cited by 78
You, L., Zhao, Y., Kuča, K., Wang, X., Olekšák, P., Chrienová, Ž., Nepovimová, E., Jacevic, V. M., Wu, Q., & Wu, W. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03030-2 · Cited by 78
Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells
Thomas, R., & Kim, M. H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.114 · Cited by 76
Angiogenesis by transplantation of HIF‐1α modified EPCs into ischemic limbs
Jiang, M., Wang, B., Wang, C., He, B., Fan, H., Guo, T. B., Shao, Q., Gao, L., & Liu, Y. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21416 · Cited by 76
HIF prolyl hydroxylase inhibitors for anemia
Muchnik, E., & Kaplan, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566861 · Cited by 76
Duyndam, M. C. A., van Berkel, M. P. A., Dorsman, J. C., Rockx, D., Pinedo, H. M., & Boven, E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.003 · Cited by 78
Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures
Jensen, R. L. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.4.16 · Cited by 76
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
Barry, R. E., & Krek, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.008 · Cited by 77
Hypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
Otrock, Z. K., Hatoum, H. A., Awada, A. H., Ishak, R. S., & Shamseddine, A. I. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.001 · Cited by 77
Smirnova, N. A., Rakhman, I., Moroz, N., Basso, M., Payappilly, J. B., Kazakov, S. V., Hernandez-Guzman, F. G., Gaisina, I. N., Kozikowski, A. P., Ratan, R. R., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.008 · Cited by 75
Horii, K., Suzuki, Y., Kondo, Y., Akimoto, M., Nishimura, T., Yamabe, Y., Sakaue, M., Sano, T., Kitagawa, T., Himeno, S., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0226 · Cited by 75
Hypoxia-inducible factor (HIF) network: insights from mathematical models
Cavadas, M. A. S., Nguyen, L. K., & Cheong, A. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-42 · Cited by 81
Sadiku, P., & Walmsley, S. R. (2019) · EMBO Reports · doi:10.15252/embr.201847388 · Cited by 79
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
Shirai, Y., Chow, C. C. T., Kambe, G., Suwa, T., Kobayashi, M., Takahashi, I., Harada, H., & Nam, J. (2021) · Cancers · doi:10.3390/cancers13112813 · Cited by 76
The role of hypoxia on prostate cancer progression and metastasis
Mohamed, O. A. A., Tesen, H. S., Hany, M., Sherif, A., Abdelwahab, M. M., & Elnaggar, M. H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08251-5 · Cited by 81
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
Sufan, R. I., Jewett, M. A. S., & Ohh, M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2003 · Cited by 73
Liu, Y., Veena, C. K., Morgan, J. B., Mohammed, K. A., Jekabsons, M. B., Nagle, D. G., & Zhou, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806744200 · Cited by 74
HIF-2α as a possible therapeutic target of osteoarthritis
Saito, T., & Kawaguchi, H. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.10.006 · Cited by 75
Imidazole Ring-Opened DNA Purines and Their Biological Significance
Tudek, B. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.012 · Cited by 75
Hypoxia-inducible factor 1 and its role in viral carcinogenesis
Cuninghame, S., Jackson, R., & Zehbe, I. (2014) · Virology · doi:10.1016/j.virol.2014.02.027 · Cited by 73
RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation
Hänze, J., Eul, B. G., Savai, R., Krick, S., Goyal, P., Grimminger, F., Seeger, W., & Rose, F. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.153 · Cited by 72
Yang, M. H., Ge, W., Chowdhury, R., Claridge, T. D. W., Kramer, H., Schmierer, B., McDonough, M. A., Gong, L., Kessler, B. M., Ratcliffe, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193540 · Cited by 73
Beischlag, T. V., Taylor, R. T., Rose, D. W., Yoon, D. Y., Chen, Y., Lee, W., Rosenfeld, M. G., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410456200 · Cited by 73
Role of copper in regression of cardiac hypertrophy
Zheng, L., Han, P., Liu, J., Li, R., Yin, W., Wang, T., Zhang, W., & Kang, Y. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.014 · Cited by 74
Ubiquitin Pathway in VHL Cancer Syndrome
Ohh, M. (2006) · Neoplasia · doi:10.1593/neo.06442 · Cited by 72
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409987200 · Cited by 73
Self-citationHypoxia signalling manipulation for bone regeneration
Drager, J., Harvey, E. J., & Barralet, J. E. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.4 · Cited by 73
MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6
Saito, K., Kondo, E., & Matsushita, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr194 · Cited by 73
Oxygen-regulated Expression of TGF-β3, a Growth Factor Involved in Trophoblast Differentiation
Schäffer, L., Scheid, A., Spielmann, P., Breymann, C., Zimmermann, R., Meuli, M., Gassmann, M., Marti, H. H., & Wenger, R. H. (2003) · Placenta · doi:10.1016/s0143-4004(03)00166-8 · Cited by 74
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
Heximer, S. P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318099c · Cited by 73
Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia‐Inducible Factors
Chen, S., & Sang, N. (2010) · BioMed Research International · doi:10.1155/2011/197946 · Cited by 73
Chen, H., & Costa, M. (2008) · BioMetals · doi:10.1007/s10534-008-9190-3 · Cited by 73
Ye, S., Price, J. C., Barr, E. W., Green, M. T., Bollinger, J. M., Jr., Krebs, C., & Neese, F. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909715g · Cited by 72
Biochemical Diversity of 2-Oxoglutarate-Dependent Oxygenases
Hausinger, R. P. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782621959-00001 · Cited by 71
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 70
Molecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 80
Barth, S., Edlich, F., Berchner‐Pfannschmidt, U., Gneuss, S., Jahreis, G., Hasgall, P. A., Fandrey, J., Wenger, R. H., & Camenisch, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032631 · Cited by 70
Chan, M. C., Atasoylu, O., Hodson, E. J., Tumber, A., Leung, I. K. H., Chowdhury, R., Gómez‐Pérez, V., Demetriades, M., Rydzik, A. M., Holt‐Martyn, J. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132004 · Cited by 71
Mucin 1 Oncoprotein Blocks Hypoxia-inducible Factor 1α Activation in a Survival Response to Hypoxia
Li, Y., Kharbanda, S. M., & Kufe, D. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610156200 · Cited by 70
Roles of Brahma and Brahma/SWI2-Related Gene 1 in Hypoxic Induction of the Erythropoietin Gene
Wang, F., Zhang, R., Beischlag, T. V., Muchardt, C., Yaniv, M., & Hankinson, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409002200 · Cited by 71
Extracellular matrix genes as hypoxia-inducible targets
Myllyharju, J., & Schipani, E. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0841-7 · Cited by 72
Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases
Daly, E. B., Wind, T., Jiang, X., Sun, L. L., & Hogg, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.11.004 · Cited by 69
Zhang, J., Zhou, H., Zhang, X., Mu, W., Hu, J., Gao-lin, L., & Li, Q. (2020) · BMC Cancer · doi:10.1186/s12885-019-6501-8 · Cited by 68
del Balzo, U., Signore, P. E., Walkinshaw, G., Seeley, T. W., Brenner, M. C., Wang, Q., Guo, G., Arend, M., Flippin, L. A., Chow, F. A., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.265181 · Cited by 71
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Castillo‐Rodríguez, R. A., Trejo‐Solís, C., Cabrera‐Cano, A., Gómez‐Manzo, S., & Dávila‐Borja, V. M. (2022) · Cancers · doi:10.3390/cancers14092291 · Cited by 70
Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Nagle, D. G., & Zhou, Y. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698783 · Cited by 68
Targeting the molecular basis for tumour hypoxia
Carroll, V. A., & Ashcroft, M. A. (2005) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399405009117 · Cited by 75
Organ Protection by Hypoxia and Hypoxia‐Inducible Factors
Bernhardt, W. M., Warnecke, C., Willam, C., Tanaka, T., Wiesener, M. S., & Eckardt, K. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35012-x · Cited by 70
Leu‐574 of human HIF‐1α is a molecular determinant of prolyl hydroxylation
Kageyama, Y., Koshiji, M., To, K. K. W., Tian, Y., Ratcliffe, P. J., & Huang, E. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-1233fje · Cited by 70
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Ortmann, B. M. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2023-000154 · Cited by 67
Seo, H., Kim, E., Na, H., & Lee, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.044 · Cited by 71
Haque, M., Wang, V. E. H., Davis, D. A., Zheng, Z., & Yarchoan, R. (2006) · Journal of Virology · doi:10.1128/jvi.00553-06 · Cited by 68
Transcriptional regulation and its misregulation in Alzheimer’s disease
Chen, X., Zhang, Y., Xu, H., & Bu, G. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-44 · Cited by 70
Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors
Görlach, A., & Kietzmann, T. (2007) · Methods in Enzymology · doi:10.1016/s0076-6879(07)35022-2 · Cited by 73
Guan, D., Su, Y., Li, Y., Wu, C., Yi, M., Peng, X., & Cui, Y. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13161 · Cited by 66
Li, T., & Brouwer, M. H. (2007) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2006.12.018 · Cited by 66
Cellular oxygen sensing in health and disease
Mole, D. R., & Ratcliffe, P. J. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0632-x · Cited by 67
Ruas, J. L., Berchner‐Pfannschmidt, U., Malik, S., Gradin, K., Fandrey, J., Roeder, R. G., Pereira, T., & Poellinger, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021824 · Cited by 67
A biologic role of HIF-1 in the renal medulla
Manotham, K., Tanaka, T., Ohse, T., Kojima, I., Miyata, T., Inagi, R., Tanaka, H., Sassa, R., Fujita, T., & Nangaku, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00220.x · Cited by 66
Chen, L., Uchida, K., Endler, A., & Shibasaki, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700423200 · Cited by 66
Baek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Hubbi, M. E., Byun, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703504200 · Cited by 65
Angiogenesis — a self-adapting principle in hypoxia
Marti, H. H. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7311-3_12 · Cited by 67
Höpfl, G., Ogunshola, O. O., & Gassmann, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8997-0_7 · Cited by 67
Protein oxidation: role in signalling and detection by mass spectrometry
Spickett, C. M., & Pitt, A. R. (2012) · Amino Acids · doi:10.1007/s00726-010-0585-4 · Cited by 65
Wiley, M. M., Sweeney, K. R., Chan, D. A., Brown, K. M., McMurtrey, C., Howard, E. W., Giaccia, A. J., & Blader, I. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147041 · Cited by 65
Stiehl, D. P., Fath, D. M., Liang, D., Jiang, Y., & Sang, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3985 · Cited by 66
Melatonin and the von Hippel–Lindau/HIF-1 oxygen sensing mechanism: A review
Vriend, J. P., & Reiter, R. J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.004 · Cited by 68
Ma, Y., Freitag, P., Zhou, J., Brüne, B., Frede, S., & Fandrey, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00115.2004 · Cited by 66
Hypoxia and Hypoxia Inducible Factors (HIF) as Important Regulators of Tumor Physiology
Acker, T., & Plate, K. H. (2004) · Cancer treatment and research · doi:10.1007/978-1-4419-8871-3_14 · Cited by 66
Sabharwal, S. S., Waypa, G. B., Marks, J. D., & Schumacker, P. T. (2013) · Biochemical Journal · doi:10.1042/bj20130740 · Cited by 65
Harnessing the Response to Tissue Hypoxia HIF-1α and Therapeutic Angiogenesis
Vincent, K. A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00186-x · Cited by 64
The Caulerpa Pigment Caulerpin Inhibits HIF-1 Activation and Mitochondrial Respiration
Liu, Y., Morgan, J. B., Coothankandaswamy, V., Liu, R., Jekabsons, M. B., Mahdi, F., Nagle, D. G., & Zhou, Y. (2009) · Journal of Natural Products · doi:10.1021/np9005794 · Cited by 64
Taylor, C. T., & Pouysségur, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.004 · Cited by 64
Datta, K., Li, J., Bhattacharya, R., Gasparian, L., Wang, E., & Mukhopadhyay, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2706 · Cited by 64
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer☆
Vleugel, M. M., SHVARTS, D., VANDERWALL, E., & VANDIEST, P. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.03.015 · Cited by 64
Modeling the regulation of p53 activation by HIF‐1 upon hypoxia
Wang, P., Guan, D., Zhang, X., Liu, F., & Wang, W. (2019) · FEBS Letters · doi:10.1002/1873-3468.13525 · Cited by 62
Metadata
- Authors
- Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L.
- Affiliations
- Adelaide University (AU)
- Commonwealth Scientific and Industrial Research Organisation (AU)
- Corresponding author
- Whitelaw, Murray L.
- Venue
- Science
- Published
- 2002-02
- Volume
- 295
- Issue
- 5556
- Pages
- 858-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1973092951
- Semantic Scholar
- 56986a3761858ed94221534104f97dacadfc3a98
- Cited by
- 1,558
- References
- 28
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 34 · 2023: 46 · 2022: 46 · 2021: 48 · 2020: 43 · 2019: 50 · 2018: 50 · 2017: 48 · 2016: 58 · 2015: 58 · 2014: 58 · 2013: 67 · 2012: 58
- FWCI
- 49.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, HIF-1α, HIF-2α, proline hydroxylation, transactivation domain, p300 coactivator, protein stability, 2-oxoglutarate-dependent dioxygenase, transcriptional activation, hypoxia
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acid Sequence, Animals, Asparagine, Cell Line, Humans, Mixed Function Oxygenases, Hydroxylation, Molecular Sequence Data, Mutation, Oxygen, Proline, Recombinant Fusion Proteins, Mass Spectrometry, Transcription Factors, Transcriptional Activation, Trans-Activators, Cell Hypoxia, Protein Structure, Tertiary, Amino Acid Substitution, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
